GlassScriptPhysician profile
Arturo E Mendoza
NPI 1649232182
$3,648.36
in general payments reported to CMS, 2019-2025
10 companies · $259 in 2025
The $259 reported for 2025 was more than what 82% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.12 · 2020: $1,567 · 2021: $403 · 2022: $1,106 · 2023: $47.63 · 2024: $252 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $1,500.00 | 2020 | |
| Biomerieux INC | $896.81 | 2022 | |
| Abbott Laboratories | $416.46 | 2019-2025 | I-Stat, Alinity M |
| Roche Diagnostics Corporation | $302.75 | 2021-2025 | Cobas 4800 Ct/Ng Test V2.0 |
| Aspira Women'S Health INC | $144.84 | 2024 | Ova1 |
| Bio-Rad Laboratories, INC. | $135.67 | 2021 | |
| Merck Sharp & Dohme LLC | $92.59 | 2021 | |
| Asuragen, INC. | $88.01 | 2022 | |
| Werfen USA LLC | $36.48 | 2024 | |
| Hologic Sales and Service, LLC | $34.75 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arturo Mendoza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.